A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia)

Study Evaluating Venetoclax in Subjects With Hematological Malignancies

NCT02265731 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of Venetoclax and Alvocidib in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT03441555 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Efficacy of Venetoclax Monotherapy in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia (CLL)

NCT02756611 ·Status: COMPLETED ·Phase: PHASE3

Clinical Study of Venetoclax Combined With CAG in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia

NCT05918198 ·Status: RECRUITING ·Phase: PHASE2

Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting

NCT03342144 ·Status: RECRUITING

Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)

NCT05182385 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

A Study of Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece

NCT04159779 ·Status: ACTIVE_NOT_RECRUITING

An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

NCT03844048 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice

NCT04178317 ·Status: COMPLETED

AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT05211570 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent).

NCT02980731 ·Status: COMPLETED ·Phase: PHASE3

Study of Venetoclax in Combination With Decitabine in Subjects With Acute Myeloid Leukemia

NCT03844815 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

NCT04898894 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy

NCT04282811 ·Status: RECRUITING

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)

NCT04895436 ·Status: RECRUITING ·Phase: PHASE2

A Phase 2 Open-Label Study of the Efficacy and Safety of ABT-199 (GDC-0199) in Chronic Lymphocytic Leukemia (CLL) Subjects With Relapse or Refractory to B-Cell Receptor Signaling Pathway Inhibitor Therapy

NCT02141282 ·Status: COMPLETED ·Phase: PHASE2

Venetoclax Based Regimen for R/R T-ALL

NCT05149378 ·Status: COMPLETED ·Phase: PHASE2

Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

NCT03826992 ·Status: RECRUITING ·Phase: PHASE1

Clinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

NCT06084819 ·Status: RECRUITING ·Phase: PHASE2

Venetoclax and Ibrutinib in Patients With Relapsed/Refractory CLL or SLL

NCT03045328 ·Status: COMPLETED ·Phase: PHASE2

A Study of Oral Venetoclax Tablet in Combination With Subcutaneous Low-Dose Cytarabine (LDAC) Injection to Assess Adverse Events in Adult Japanese Participants With Acute Myeloid Leukemia (AML)

NCT04509622 ·Status: COMPLETED ·Phase: PHASE3

8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT05263284 ·Status: SUSPENDED ·Phase: PHASE1

A Study of Venetoclax in Combination With Chemotherapy to Treat Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

NCT05386576 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1

A Study to Describe the Effectiveness and Safety of Venetoclax Treatment in Chronic Lymphocytic Leukemia (CLL) Patients in Routine Clinical Practice

NCT03659669 ·Status: SUSPENDED

A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy

NCT03069352 ·Status: COMPLETED ·Phase: PHASE3